Skip to main content

Advertisement

Table 1 Participant characteristics of a randomized controlled trial evaluating a web-based intervention for improving self-reported cognitive functioning in adult cancer survivors

From: Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog)

  Intervention N = 121 Control N = 121 Combined N = 242
Female 116 (96%) 114 (94%) 230 (95%)
Age (range); years 52 (23–74) 54 (31–74) 53 (23–74)
Median education (range); years 14 (8–19) 12 (3–19) 13 (8–19)
English as first language 117 (97%) 117 (97%) 234 (97%)
Primary tumor type
 Breast 108 (89%) 108 (89%) 216 (89%)
 Colorectal 6 (5%) 7 (6%) 13 (5%)
 Other 7 (6%) 6 (5%) 13 (5%)
Time since completion of chemotherapy, months, mean (range) 27 (6–57) 27 (6–60) 27 (6–60)
Radiotherapy 86 (71%) 78 (64%) 164 (68%)
Immune therapy 30 (25%) 24 (20%) 54 (22%)
Hormone therapy 84 (69%) 85 (70%) 171 (71%)
Previous neurological historya 20 (17%) 30 (25%) 50 (21%)
  1. aDefined as: held back a grade in school; required remedial help at school; diagnosed with a learning disability; head injury with loss of consciousness with residual sequelae; history of seizures, dementia, coma, epilepsy, cardiac arrest requiring cardiopulmonary resuscitation, stroke; history of other neurological risk; or history of significant alcohol abuse